Protective effects of Indian spice curcumin against Amyloid-ß in Alzheimer's disease

P (Hemachandra) Reddy, Maria Manczak, Xiangling Yin, Mary Catherine Grady, Andrew Mitchell, Sahil Tonk, Chandra Sekhar Kuruva, Jasvinder Singh Bhatti, Ramesh Kandimalla, Murali Vijayan, Subodh Kumar, Rui Wang, Jangampalli Adi Pradeepkiran, Gilbert Ogunmokun, Kavya Thamarai, Kandi Quesada, Annette Boles, Arubala Reddy

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

The purpose of our article is to assess the current understanding of Indian spice, curcumin, against amyloid-ß (Aß)-induced toxicity in Alzheimer's disease (AD) pathogenesis. Natural products, such as ginger, curcumin, and gingko biloba have been used as diets and dietary supplements to treat human diseases, including cancer, cardiovascular, respiratory, infectious, diabetes, obesity, metabolic syndromes, and neurological disorders. Products derived from plants are known to have protective effects, including anti-inflammatory, antioxidant, anti-arthritis, pro-healing, and boosting memory cognitive functions. In the last decade, several groups have designed and synthesized curcumin and its derivatives and extensively tested using cell and mouse models of AD. Recent research on Aß and curcumin has revealed that curcumin prevents Aß aggregation and crosses the blood-brain barrier, reach brain cells, and protect neurons from various toxic insults of aging and Aß in humans. Recent research has also reported that curcumin ameliorates cognitive decline and improves synaptic functions in mouse models of AD. Further, recent groups have initiated studies on elderly individuals and patients with AD and the outcome of these studies is currently being assessed. This article highlights the beneficial effects of curcumin on AD. This article also critically assesses the current limitations of curcumin's bioavailability and urgent need for new formulations to increase its brain levels to treat patients with AD.

Original languageEnglish (US)
Pages (from-to)843-866
Number of pages24
JournalJournal of Alzheimer's Disease
Volume61
Issue number3
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Spices
Curcumin
Amyloid
Alzheimer Disease
Ginger
Ginkgo biloba
Poisons
Brain
Dietary Supplements
Nervous System Diseases
Biological Products
Blood-Brain Barrier
Research
Cognition
Biological Availability
Arthritis
Anti-Inflammatory Agents
Obesity
Antioxidants
Outcome Assessment (Health Care)

Keywords

  • Alzheimer's disease
  • Amyloid-ß
  • Amyloid-ß protein precursor
  • Curcumin
  • Mitochondria
  • Oxidative stress
  • Reactive oxygen species

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Reddy, P. H., Manczak, M., Yin, X., Grady, M. C., Mitchell, A., Tonk, S., ... Reddy, A. (2018). Protective effects of Indian spice curcumin against Amyloid-ß in Alzheimer's disease. Journal of Alzheimer's Disease, 61(3), 843-866. https://doi.org/10.3233/JAD-170512

Protective effects of Indian spice curcumin against Amyloid-ß in Alzheimer's disease. / Reddy, P (Hemachandra); Manczak, Maria; Yin, Xiangling; Grady, Mary Catherine; Mitchell, Andrew; Tonk, Sahil; Kuruva, Chandra Sekhar; Bhatti, Jasvinder Singh; Kandimalla, Ramesh; Vijayan, Murali; Kumar, Subodh; Wang, Rui; Pradeepkiran, Jangampalli Adi; Ogunmokun, Gilbert; Thamarai, Kavya; Quesada, Kandi; Boles, Annette; Reddy, Arubala.

In: Journal of Alzheimer's Disease, Vol. 61, No. 3, 01.01.2018, p. 843-866.

Research output: Contribution to journalReview article

Reddy, PH, Manczak, M, Yin, X, Grady, MC, Mitchell, A, Tonk, S, Kuruva, CS, Bhatti, JS, Kandimalla, R, Vijayan, M, Kumar, S, Wang, R, Pradeepkiran, JA, Ogunmokun, G, Thamarai, K, Quesada, K, Boles, A & Reddy, A 2018, 'Protective effects of Indian spice curcumin against Amyloid-ß in Alzheimer's disease', Journal of Alzheimer's Disease, vol. 61, no. 3, pp. 843-866. https://doi.org/10.3233/JAD-170512
Reddy, P (Hemachandra) ; Manczak, Maria ; Yin, Xiangling ; Grady, Mary Catherine ; Mitchell, Andrew ; Tonk, Sahil ; Kuruva, Chandra Sekhar ; Bhatti, Jasvinder Singh ; Kandimalla, Ramesh ; Vijayan, Murali ; Kumar, Subodh ; Wang, Rui ; Pradeepkiran, Jangampalli Adi ; Ogunmokun, Gilbert ; Thamarai, Kavya ; Quesada, Kandi ; Boles, Annette ; Reddy, Arubala. / Protective effects of Indian spice curcumin against Amyloid-ß in Alzheimer's disease. In: Journal of Alzheimer's Disease. 2018 ; Vol. 61, No. 3. pp. 843-866.
@article{de0402ffdf614a48b7077b216a4d99eb,
title = "Protective effects of Indian spice curcumin against Amyloid-{\ss} in Alzheimer's disease",
abstract = "The purpose of our article is to assess the current understanding of Indian spice, curcumin, against amyloid-{\ss} (A{\ss})-induced toxicity in Alzheimer's disease (AD) pathogenesis. Natural products, such as ginger, curcumin, and gingko biloba have been used as diets and dietary supplements to treat human diseases, including cancer, cardiovascular, respiratory, infectious, diabetes, obesity, metabolic syndromes, and neurological disorders. Products derived from plants are known to have protective effects, including anti-inflammatory, antioxidant, anti-arthritis, pro-healing, and boosting memory cognitive functions. In the last decade, several groups have designed and synthesized curcumin and its derivatives and extensively tested using cell and mouse models of AD. Recent research on A{\ss} and curcumin has revealed that curcumin prevents A{\ss} aggregation and crosses the blood-brain barrier, reach brain cells, and protect neurons from various toxic insults of aging and A{\ss} in humans. Recent research has also reported that curcumin ameliorates cognitive decline and improves synaptic functions in mouse models of AD. Further, recent groups have initiated studies on elderly individuals and patients with AD and the outcome of these studies is currently being assessed. This article highlights the beneficial effects of curcumin on AD. This article also critically assesses the current limitations of curcumin's bioavailability and urgent need for new formulations to increase its brain levels to treat patients with AD.",
keywords = "Alzheimer's disease, Amyloid-{\ss}, Amyloid-{\ss} protein precursor, Curcumin, Mitochondria, Oxidative stress, Reactive oxygen species",
author = "Reddy, {P (Hemachandra)} and Maria Manczak and Xiangling Yin and Grady, {Mary Catherine} and Andrew Mitchell and Sahil Tonk and Kuruva, {Chandra Sekhar} and Bhatti, {Jasvinder Singh} and Ramesh Kandimalla and Murali Vijayan and Subodh Kumar and Rui Wang and Pradeepkiran, {Jangampalli Adi} and Gilbert Ogunmokun and Kavya Thamarai and Kandi Quesada and Annette Boles and Arubala Reddy",
year = "2018",
month = "1",
day = "1",
doi = "10.3233/JAD-170512",
language = "English (US)",
volume = "61",
pages = "843--866",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Protective effects of Indian spice curcumin against Amyloid-ß in Alzheimer's disease

AU - Reddy, P (Hemachandra)

AU - Manczak, Maria

AU - Yin, Xiangling

AU - Grady, Mary Catherine

AU - Mitchell, Andrew

AU - Tonk, Sahil

AU - Kuruva, Chandra Sekhar

AU - Bhatti, Jasvinder Singh

AU - Kandimalla, Ramesh

AU - Vijayan, Murali

AU - Kumar, Subodh

AU - Wang, Rui

AU - Pradeepkiran, Jangampalli Adi

AU - Ogunmokun, Gilbert

AU - Thamarai, Kavya

AU - Quesada, Kandi

AU - Boles, Annette

AU - Reddy, Arubala

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The purpose of our article is to assess the current understanding of Indian spice, curcumin, against amyloid-ß (Aß)-induced toxicity in Alzheimer's disease (AD) pathogenesis. Natural products, such as ginger, curcumin, and gingko biloba have been used as diets and dietary supplements to treat human diseases, including cancer, cardiovascular, respiratory, infectious, diabetes, obesity, metabolic syndromes, and neurological disorders. Products derived from plants are known to have protective effects, including anti-inflammatory, antioxidant, anti-arthritis, pro-healing, and boosting memory cognitive functions. In the last decade, several groups have designed and synthesized curcumin and its derivatives and extensively tested using cell and mouse models of AD. Recent research on Aß and curcumin has revealed that curcumin prevents Aß aggregation and crosses the blood-brain barrier, reach brain cells, and protect neurons from various toxic insults of aging and Aß in humans. Recent research has also reported that curcumin ameliorates cognitive decline and improves synaptic functions in mouse models of AD. Further, recent groups have initiated studies on elderly individuals and patients with AD and the outcome of these studies is currently being assessed. This article highlights the beneficial effects of curcumin on AD. This article also critically assesses the current limitations of curcumin's bioavailability and urgent need for new formulations to increase its brain levels to treat patients with AD.

AB - The purpose of our article is to assess the current understanding of Indian spice, curcumin, against amyloid-ß (Aß)-induced toxicity in Alzheimer's disease (AD) pathogenesis. Natural products, such as ginger, curcumin, and gingko biloba have been used as diets and dietary supplements to treat human diseases, including cancer, cardiovascular, respiratory, infectious, diabetes, obesity, metabolic syndromes, and neurological disorders. Products derived from plants are known to have protective effects, including anti-inflammatory, antioxidant, anti-arthritis, pro-healing, and boosting memory cognitive functions. In the last decade, several groups have designed and synthesized curcumin and its derivatives and extensively tested using cell and mouse models of AD. Recent research on Aß and curcumin has revealed that curcumin prevents Aß aggregation and crosses the blood-brain barrier, reach brain cells, and protect neurons from various toxic insults of aging and Aß in humans. Recent research has also reported that curcumin ameliorates cognitive decline and improves synaptic functions in mouse models of AD. Further, recent groups have initiated studies on elderly individuals and patients with AD and the outcome of these studies is currently being assessed. This article highlights the beneficial effects of curcumin on AD. This article also critically assesses the current limitations of curcumin's bioavailability and urgent need for new formulations to increase its brain levels to treat patients with AD.

KW - Alzheimer's disease

KW - Amyloid-ß

KW - Amyloid-ß protein precursor

KW - Curcumin

KW - Mitochondria

KW - Oxidative stress

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=85044773243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044773243&partnerID=8YFLogxK

U2 - 10.3233/JAD-170512

DO - 10.3233/JAD-170512

M3 - Review article

VL - 61

SP - 843

EP - 866

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -